# Cancer Center Support Grant

> **NIH NIH P30** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2022 · $150,000

## Abstract

Project Summary
Since the last competitive review of this Cancer Center Support Grant (CCSG) in 2012, the NCI-designated
Perlmutter Cancer Center (PCC), previously NYU Cancer Institute, has weathered the devastation of Superstorm
Sandy and emerged into a period of profound transformation and expansion. Propelled by a transformative gift
from Laurie and Isaac Perlmutter, renewed and enhanced institutional support from the NYU Langone Health
system (NYULH) and a new Director, we have overhauled our leadership team, expanded our clinical and
research facilities, and developed a new strategic vision and began implementing a new Strategic Plan. Guided
by this plan, our Scientific Programs and Shared Resources have been restructured, and we embarked on a
major recruitment campaign that has yielded 12 additional new leadership and/or senior faculty recruits, 15 other
new cancer center faculty recruits, and 68 new members overall. Under revised, more stringent criteria,
membership has been streamlined to 180 full members and 56 associate members. Members carry out research
as part of 5 Scientific Programs, Cancer Genome Dynamics, Cancer Cell Biology, Tumor Immunology,
Melanoma, or Epidemiology and Cancer Control, assisted by 10 Shared Resources and 2 Developing Shared
Resources. Our clinical trials office has been reorganized and substantially expanded under new leadership and
a new Phase I unit has opened. Subsequently, trial availability, quality, and accrual have increased, while the
time to trial opening has been markedly reduced. In line with our increased geographic scope and patient
population, we have redefined and enlarged our catchment area. Aided by the creation of a new Department of
Population Health at NYU Langone School of Medicine and the College of Global Public Health at the NYU main
campus, our Population Sciences research has increased in breadth and quality. Most importantly, our laboratory
scientists have made paradigm-shifting discoveries, our clinicians have led multiple practice-changing trials, and
our population scientists have yielded new insights into the causes of cancer and how to control the disease,
contributed to major public health policy changes and initiatives, and established new community outreach
programs that address the specific cancer burdens and health disparities in our catchment area. Although PCC
is located in a city with four other NCI-designated cancer centers, our catchment area differs substantially from
the others: we are the major provider to lower Manhattan, and have expanded into Brooklyn, the largest and
fastest growing borough in New York City, as well as to Queens and Long Island.

## Key facts

- **NIH application ID:** 10643036
- **Project number:** 3P30CA016087-41S3
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** BENJAMIN G. NEEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $150,000
- **Award type:** 3
- **Project period:** 2022-09-01 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10643036

## Citation

> US National Institutes of Health, RePORTER application 10643036, Cancer Center Support Grant (3P30CA016087-41S3). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10643036. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*